Regulatory T cells in transplantation tolerance

Nature Reviews Immunology

Volumn 3, Issue 3, 2003, Pages 199-210

  Wood, Kathryn J ^a   Sakaguchi, Shimon ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CALCINEURIN INHIBITOR; CALCITRIOL; CD4 ANTIGEN; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY CD3;

ANTIGEN RECOGNITION; CELLULAR DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSPLANTATION; TRANSPLANTATION TOLERANCE; ANIMAL; GRAFT REJECTION; HISTOCOMPATIBILITY; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; REGULATORY T LYMPHOCYTE; SPECIES DIFFERENCE;

ANIMALS; ANTIGENS, CD4; GRAFT REJECTION; HUMANS; ISOANTIGENS; LYMPHOCYTE SUBSETS; RECEPTORS, INTERLEUKIN-2; SPECIES SPECIFICITY; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 0037364976     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1027     Document Type: Review

References (138)

1. Bach, J-F. Regulatory T cells under scrutiny. Nature Rev. Immunol. 3, 189-198 (2003).
2. Wells, A., Li, X., Strom, T. & Turka, L. The role of peripheral T-cell deletion in transplantation tolerance. Phil. Trans. R. Soc. Lond. B 356, 617-623 (2001).
3. Wood, K. J., Jones, N., Bushell, A. & Morris, P. J. Alloantigen-induced specific immunological unresponsiveness. Phil Trans. R. Soc. Lond. B 356, 665-680 (2001).
4. Gershon, R. & Kondo, K. Infectious immunological tolerance. Immunology 21, 903-914 (1971).
5. Kishaw, P., Brent, L. & Pinto, M. Suppressor T cells in mice made unresponsive to skin allografts. Nature 255, 489-491 (1975).
6. Hutchinson, I. V. Suppressor T cells in allogeneic models. Transplantation 41, 547-555 (1986).
7. Gilliet, M. & Liu, Y.-J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 195, 695-704 (2002).
8. - regulatory cells. J. Immunol. 167, 107-113 (2001).
9. + CD28-regulatory T cells. J. Immunol. 161, 5193-5202 (1998).
10. Zhang, Z., Yang, L., Young, K., DuTemple, B. & Zhang, L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nature Med. 6, 782-789 (2000).
11. + T cells reciprocally regulate acute graft-versus-host disease. Blood 99, 1449-1457 (1999).
12. Seino, K.-I. et al. Requirement for natural killer T (NKT cells in the induction of allograft tolerance. Proc. Natl Acad. Sci. USA 98, 2577-2581 (2001).
13. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193, 1311-1318 (2001).
14. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196, 389-399 (2002).
15. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196, 401-406 (2002).
16. Chambers, C. A. et al. The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK-cell receptor. Blood 99, 4509-4516 (2002).
17. Reg) cells have an important role in the maintenance of self-tolerance.
18. + suppressor T cells. J. Exp. Med. 193, F41-F45 (2001).
19. + suppressor cell and its mechanism of action. J. Exp. Med. 171, 141-157 (1990).
20. Reg cells to maintain tolerance in vivo.
21. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080-1086 (2002).
22. Sanchez-Fueyo, A., Weber, M., Domenig, C., Strom, T. & Zheng, X. Tracking immunoregulatory mechanisms during allograft tolerance. J. Immunol. 168, 2274-2281 (2002).
23. - regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168, 5558-5565 (2002).
24. + high regulatory cells in human peripheral blood. J. Immunol. 167, 1245-1253 (2001).
25. + T regulatory cells suppress naive and memory T-cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193, 1295-1301 (2001).
26. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 139, 1285-1294 (2001).
27. + cells: a naturally occurring population of regulatory T cells Blood 98, 2735-2744 (2001).
28. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31, 1247-1254 (2001).
29. + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31, 1122-1131 (2001).
30. Reg cells are present in humans.
31. Vincenti, F. Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens Transplant. Proc. 33, 3169-3171 (2001).
32. + T cells as a functionally and phenotypically distinct immunoregulatory T-cell subpopulation. Int. Immunol. 12, 1145-1155 (2000).
33. - subpopulations. J. Immunol. 165, 3105-3110 (2000).
34. Herold, K. et al. Anti-CD3 monoclonal antibody in new onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1740-1742 (2002). A clinical study showing that therapy with CD3-specific monoclonal antibodies has the potential to control the progression of diabetes.
35. Shoskes, D. & Wood, K. Indirect presentation of MHC antigens in transplantation. Immunol. Today 15, 1-7 (1994).
36. Lechler, R. I. & Batchelor, J. R. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor-strain dendritic cells. J. Exp. Med. 155, 31-41 (1982).
37. Auchincloss, H. et al. The role of 'indirect' recognition in initiating rejection of skin grafts from major histocompatibility complex class-II-deficient mice. Proc. Natl. Acad. Sci. USA 90, 3373-3377 (1993).
38. Wise, M. P., Bemelman, F., Cobbold, S. P. & Waldmann, H. Linked suppression of skin graft rejection can operate through indirect recognition. J. Immunol. 161, 5813-5816 (1998).
39. Yamada, A. et al. Cutting edge: recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J. Immunol. 167, 5522-5526 (2001). An elegant demonstration that the indirect pathway of allorecognition is required for long-term allograft survival.
40. Blancho, G. et al. Molecular and cellular events implicated in local tolerance to kidney allografts in miniature swine. Transplantation 63, 26-33 (1997).
41. Sayegh, M. H., Khoury, S., Hancock, W., Weiner, H. & Carpenter, C. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat, Proc. Natl. Acad. Sci. USA 89, 7762-7766 (1992).
42. Niimi, M. et al. Non-depleting anti-CD4 antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts. Transplantation 70, 1524-1548 (2000).
43. Lagaaij, E. L. et al. Effect of one-HLA-DR antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N. Engl. J. Med. 321, 701-705 (1989).
44. Claas, F., de Koster, H. & van Rood, J. A molecular mechanism of T-cell downregulation by blood transfusion. Exp. Nephrol. 1, 134-138 (1993).
45. + regulatory T cells: their common role in controlling autoimmunity, tumour immunity and transplantation tolerance. Immunol. Rev. 182, 18-32 (2001).
46. van Maurik, A., Wood, K. J. & Jones, N. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway. Transplantation 74, 740-743 (2002).
47. + T-cell tolerance and linked suppression. J. Immunol. 163, 4805-4810 (1999).
48. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104, 1715-1722 (1999).
49. + T cells can trigger allograft rejection. J. Immunol. 165, 1111-1118 (2000).
50. + T cells contribute to the development of transplant ateriosclerosis despite CD154 blockade. Transplantation 69, 2609-2612 (2000).
51. + alloantigen-specific immunoregulatory cells that can prevent CD8-T-cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169, 5401-5404 (2002).
52. + T cells.
53. + immunoregulatory cells. J. Immunol. 167, 1137-1140 (2001).
54. + regulatory T cells down-regulate costimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538-1543 (2000).
55. Qin, S. et al. 'Infectious' transplantation tolerance. Science 259, 974-977 (1993).
56. + T helper cells. J. Exp. Med. 196, 255-260 (2002).
57. + regulatory, contact-dependent T cells induce interleukin-10-producing, contact-independent type 1-like regulatory T cells. J. Exp. Med. 196, 247-253 (2002).
58. Onodera, K. et al. Type 2 helper T cell-type cytokines and the development of 'infectious' tolerance in rat cardiac allograft recipients. J. Immunol. 158, 1572-1581 (1997).
59. Madsen, J. C., Superina, R. A., Wood, K. J. & Morris, P. J. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 332, 161-164 (1988). Exposure to a single donor alloantigen is sufficient to induce specific unresponsiveness to a fully allogeneic graft, which provides evidence for linked unresponsiveness.
60. + T cells in the induction of tolerance to class I molecules. Transplantation 61, 1532-1538 (1996).
61. Wong, W., Morris, P. & Wood, K. Pretransplant administration of a single donor class I MHC molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation 63, 1490-1494 (1997).
62. Davies, J. D., Leong, L. Y., Mellor, A., Cobbold, S. P. & Waldmann, H. T-cell suppression in transplantation tolerance through linked recognition. J. Immunol. 156, 3602-3607 (1996).
63. Sonrag, K.-C. et al. Tolerance to solid organ transplants through transfer of MHC class II genes. J. Clin. Invest. 107, 65-71 (2001).
64. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
65. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183-190 (2000).
66. Reg cells in transplants.
67. H2 gene transcripts. J. Immunol. 168, 1069-1079 (2002).
68. + regulatory T cells. J. Exp. Med. 194, 847-854 (2001).
69. + human thymocytes. J. Exp. Med. 196, 379-387 (2002).
70. Bystry, R., Aluvihare, V., Welch, K., Kallikourdis, M. & Betz, A. B cells and professional APCs recruit regulatory T cells. Nature Immunol. 2, 1126-1132 (2001).
71. Sawitzki, B. et al. Gene expression associated with tolerance and rejection - expression kinetics in different transplant models. Transplantation. 74, S244 (2002).
72. Mason, D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19, 395-404 (1998).
73. Reg cells is another important contribution of the thymus to the maintenance of self-tolerance.
74. Sakaguchi, S. et al. in Novartis Foundation Symposium 252. Generation and Effector Functions of Regulatory Lymphocytes (Wiley, Europe) (in the press).
75. Mogdigliani, Y. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur. J. Immunol. 26, 1807-1815 (1996).
76. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nature Immunol. 3, 756-763 (2002).
77. + regulatory T cells. Eur. J. Immunol. 32, 1621-1630 (2002).
78. Hamano, K., Rawsthorne, M, Bushell, A., Morris, P. & Wood, K. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for the maintenance of tolerance to alloantigen in anti-CD4-treated recipients. Transplantation 62, 856-860 (1996).
79. Karim, M., Steger, U., Bushell, A. & Wood, K. J. The role of the graft in establishing tolerance. Frontiers Biosci. 7, 129-154 (2002).
80. Konieczny, B. et al. IFN-γ is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T-cell costimulation pathways. J. Immunol. 160, 2059-2064 (1998).
81. Papiernik,M., de Moreas, M., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2R α-chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371-378 (1998).
82. Larsen, P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996).
83. Kirk, A. et al, Treatment with humanised monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med. 5, 686-693 (1999).
84. Reg cells.
85. Asseman, C., Mauze, S., Leach, M., Coffman, R. & Powne, F. An essential role for interleukin-10 in the function of regulatory T cells which inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004 (1999).
86. Josien, R. et al. A critical role for transforming growth factor-β in donor transfusion-induced allograft tolerance. J. Clin. Invest. 102, 1920-1926 (1998).
87. Bickerstaff, A., VanBuskirk, A., Wakely, E. & Orosz, G. Transforming growth factor-β and interleukin-10 subvert delayed-type hypersensitivity in cardiac allograft acceptor mice. Transplantation 69, 1517-1520 (2000).
88. + T cells. J. Exp. Med. 183, 2669-2674 (1996).
89. + regulatory T cells is mediated by cell surface-bound transforming growth factor-β. J. Exp. Med. 194, 629-644 (2001).
90. + immunoregulatory T cells suppress polyclonal activation by inhibiting interleukin-2 production. J. Exp. Med. 188, 287-296 (1998).
91. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor-β1 production and responsiveness. J. Exp. Med. 196, 237-246 (2002).
92. Sullivan, T. J. et al. Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T-cell activation. Proc. Natl. Acad. Sci. USA 98, 2587-2592 (2001).
93. Walunas, T. et al. CTLA-4 can function as a negative regulator of T-cell activation. Immunity 1, 405-413 (1994).
94. Waterhouss, P. et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988 (1995).
95. + regulatory T cells constitutively expressing cytotoxic T-lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310 (2000).
96. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
97. Salomon, B. & Bluestone, J. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225-252 (2001).
98. + T cells with regulatory properties from human blood. J. Exp. Med. 139, 1303-1310 (2001).
99. + immunoregulatory T cells that control autoimmune disease. Immunity. 12, 431-440 (2000).
100. Liu, Z. et al. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J. Immunol. 167, 1830-1838 (2001).
101. + immunoregulatory T cells: gene expression anaysis reveals a functional role for the glucocorticoid-induced TNF receptor Immunity 16, 311-323 (2002).
102. Wood, K. J. et al. In Novartis Foundation Symposium 252. Generation and Effector Functions of Regulatory Lymphocytes (Wiley, Europa) (in the press).
103. Taams, L., Boot, E., van Eden, W. & Wauben, M. 'Anergic' T cells modulate the T-cell-activating capacity of antigen-presenting cells. J. Autoimmun. 14, 335-341 (2000).
104. + T cells can act as suppressor cells by affecting autologous dendritic-cell conditioning and survival. J. Immunol. 188, 1060-1068 (2002).
105. Gregon, S. et al. Regulatory T cells induced by 1α 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945-1953 (2001).
106. Hon, S., Nomura, T. & Sakaguchi, S. Control of regulatory T-cell development by transcription factor FOXP3. Science (in the press).
107. Ho, I. & Glimcher, L. H. Transcription factors: tantalizing times for T cells. Cell 109, S109-S120 (2003).
108. WiJdin, R., Smyk-Pearson, S. & Filipovich, H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy enteropathy, X-linked (IPEX) syndrome. J. Med. Genet. 39, 537-545 (2002).
109. Brunkow, M. E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genet. 27, 68-73 (2001).
110. + regulatory T-cell function. J. Exp. Med. 196, 851-857 (2002).
111. Wells, A. et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nature Med. 5. 1303-1307 (1999).
112. Li, Y. et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nature Med. 5, 1298-1302 (1999).
113. Opelz, G. Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Collaborative transplant study. Transplantation 15, 1220-1224 (1995).
114. Caine, R. et al. Prope tolerance, perioperative Campath 1H and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 351, 1701-1702 (1998).
115. Takatsuki, M. et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 72, 449-454 (2001).
116. Kupiec-Weglinski, J. W., Filho, M., Strom, T. & Tilney, N. Sparing of suppressor cells: a critical action of cyclosporine. Transplantation 38, 97-101 (1984).
117. Jones, T. R. et al. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts. J. Immunol. 168, 1123-1130 (2002).
118. + regulatory T cells from human peripheral blood. J. Immunol. 166, 7282-7289 (2001).
119. H2-inducing cytokines. J. Exp. Med. 195, 603-616 (2002).
120. + regulatory T cells by the neuropeptide α-melanocyte stimulating hormone (α-MSH). Immunol. Cell Biol. 79, 358-367 (2001).
121. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499 (2002).
122. Arnold, B., Schonnch, G. & Hammerling, G. J. Multiple levels of peripheral tolerance. Immunol. Today 14, 12-14 (1993).
123. Scully, R., Qin, S., CobboJd, S. & Waldmann, H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur. J. Immunol. 24, 2383-2392 (1994).
124. Hamano, K., Fujikura, Y., Fukada, S., Esato, K & Fukumoto, T. The effect of intrathymic injection of donor blood on the graft-versus-host reaction and cardiac allograft survival in the rat. Immunol. Cell Biol. 69, 185-189 (1991).
125. Khan, A., Tomita, Y & Sykes, M. Thymic dependence of loss of tolerance in mixed allogeneic bone-marrow chimeras after depletion of donor antigen. Transplantation 62, 380-387 (1996).
126. Manilay, J., Pearson, D., Sergio, J., Swenson, K. & Sykes, M. Intrathymic deletion of alloreactive T cells in mixed bone-marrow chimeras prepared with a nonmyeloablative conditioning regime. Transplantation 66, 96-102 (1998).
127. Lombardi, G., Sidhu, S., Batchelor, R. & Lechler, R. Anergic T cells as suppressor cells in vitro. Science 264, 1587-1589 (1994).
128. Bishop, G., Sun, J., Sheil, A. & McCaughan, G. High dose/activation-associated tolerance: a mechanism for allograft tolerance. Transplantation 64, 1377-1382 (1997).
129. + T cells. J. Immunol. 144, 3288-3295 (1990).
130. + T cells induce or protect from chronic intestinal inflammation in CB-17 scid mice. Int Immunol. 5, 1461-1471 (1993).
131. + T cells. J. Exp. Med. 178, 237-244 (1993).
132. low-density cells from untreated mice prevent acute allograft rejection. J. Immunol. 163, 5353-5357 (1999).
133. Linsley, P. S. et al. CTLA-4 is a second receptor for the B-cell activation antigen B7. J. Exp. Med. 174, 561-569 (1991).
134. Linsley, P. S. & Ledbetter, J. A. The role of the CD28 receptor during T-cell responses to antigen. Annu. Rev. Immunol. 11, 191-212 (1993).
135. Engen, J. & Allison, J. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16, 23-35 (2002).
136. Nocentini, G. et al. A new member of the tumour-necrosis factor/nerve growth factor receptor family inhibits T-cell receptor-induced apoptosis. Proc. Natl Acad. Sci. USA 94, 6216-6221 (1997).
137. + suppressor cells in vivo. Nature Immunol. 3, 33-41 (2002).
138. - regulatory T cells. Proc. Natl Acad. Sci. USA 99, 13031-13036 (2002).